Top Markets
Coin of the day
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
株式のランク #20222
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
株価
$1.91
時価総額
$136.47M
変化(1日)
-1.15%
変化(1年)
21.17%
TW
取引 Sinew Pharma Inc. (6634)

カテゴリー

Sinew Pharma Inc.(6634)の株価履歴
終値の最高値: $1.89 (2026-08-01)

終値の最安値: $1.60 (2017-06-01)
Sinew Pharma Inc. の株価履歴(2017 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 19.74%
2025 -14.90%
2024 -33.41%
2023 -38.58%
2022 20.56%
2021 26.00%
2020 195.09%
2019 88.41%
2018 -46.85%
2017 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$547.80 38.64%
US
$1.01K 53.55%
NL
$119.27 -15.19%
AU
$766.03 8.39%
CH
$132.57 388.82%
US